Skip to main content
. 2022 Jun 3;9:875021. doi: 10.3389/fcvm.2022.875021

Table 3.

Characteristics of each patient treated with VA-ECMO with or without AngioJet percutaneous rheolytic thrombectomy.

Sex/age (years) Massive/submassive Etiology Clinical manifestations RV/LV diameter ratio PESI score Thrombolysis contraindicated Treatment
F/60 Submassive Recent surgery, recent stroke Dyspnea, chest pain, syncope, cardiac arrest 1.01 110 No ECMO
M/57 Submassive Lung cancer, recent surgery Dyspnea, chest pain, presyncope 1.12 110 No ECMO
F/27 Massive Recent trauma with shock Dyspnea, chest pain, presyncope 1.20 110 Yes ECMO
M/40 Massive Recent trauma with shock Dyspnea, chest pain, syncope, shock 1.13 120 Yes ECMO
M/32 Massive Idiopathic hypercoagulability Dyspnea, chest pain, syncope, cardiac arrest 1.67 140 No ECMO+PMT
M/67 Submassive Recent surgery, active bleeding Dyspnea, chest pain, presyncope 1.53 130 Yes ECMO+PMT
M/69 Massive Recent surgery Dyspnea, chest pain, cardiac arrest 1.47 130 No ECMO+PMT
M/72 Massive Idiopathic hypercoagulability Dyspnea, chest pain, presyncope 1.43 140 No ECMO+PMT
M/68 Submassive Recent trauma with shock Dyspnea, chest pain, cardiac arrest 1.40 130 Yes ECMO+PMT

VA-ECMO, venoarterial extracorporeal membrane oxygenation; PMT, percutaneous mechanical thrombectomy (AngioJet percutaneous rheolytic thrombectomy); RV, right ventricular; LV, left ventricular; PESI, Pulmonary Embolism Severity Index; F, female; M, male.